# Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.

> **NCT05950204** · NA · UNKNOWN · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 40 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Vitamin d Deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** ω-3 polyunsaturated fatty acids (DHA and EPA), Vitamin D (cholecalciferol), Calcium (calcium carbonate)

## Key facts

- **NCT ID:** NCT05950204
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05950204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05950204, "Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05950204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*